These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6727572)

  • 1. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats.
    Laczi F; Gaffori O; Fekete M; de Kloet ER; de Wied D
    Life Sci; 1984 Jun; 34(24):2385-91. PubMed ID: 6727572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats.
    Laczi F; Gaffori O; De Kloet ER; De Wied D
    Brain Res; 1983 Dec; 280(2):309-15. PubMed ID: 6652491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of beta-endorphin-like immunoreactivity in CSF following behavioral training using a passive avoidance procedure.
    Wan RQ; Wiegant VM; de Jong W; de Wied D
    Psychoneuroendocrinology; 1996 Aug; 21(6):503-13. PubMed ID: 8983087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior.
    Laczi F; Gaffori O; de Kloet ER; de Wied D
    Brain Res; 1983 Feb; 260(2):342-6. PubMed ID: 6831206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined restraint and cold stress in rats: effects on memory processing in passive avoidance task and on plasma levels of ACTH and corticosterone.
    Klenerová V; Jurcovicová J; Kaminský O; Sída P; Krejcí I; Hlinák Z; Hynie S
    Behav Brain Res; 2003 Jun; 142(1-2):143-9. PubMed ID: 12798275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats.
    Kovács GL; Buijs RM; Bohus B; van Wimersma Greidanus TB
    Physiol Behav; 1982 Jan; 28(1):45-8. PubMed ID: 7079322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response.
    Croiset G; Heijnen CJ; de Wied D
    Neuroendocrinology; 1990 Feb; 51(2):156-61. PubMed ID: 2106096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH release during passive avoidance behavior.
    Van Wimersma Greidanus TB; Rees LH; Scott AP; Lowry PJ; De Wied D
    Brain Res Bull; 1977; 2(2):101-4. PubMed ID: 195676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressinergic modulation of stress responses in the central amygdala of the Roman high-avoidance and low-avoidance rat.
    Roozendaal B; Wiersma A; Driscoll P; Koolhaas JM; Bohus B
    Brain Res; 1992 Nov; 596(1-2):35-40. PubMed ID: 1468000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dimorphism in passive avoidance behavior of rats: relation to body weight, age, shock intensity and retention interval.
    Drago F; Bohus B; Scapagnini U; de Wied D
    Physiol Behav; 1980 Jun; 24(6):1161-4. PubMed ID: 7413797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine vasopressin, stress, and memory.
    Koob GF; Lebrun C; Martinez JL; Dantzer R; Le Moal M; Bloom FE
    Ann N Y Acad Sci; 1985; 444():194-202. PubMed ID: 3860087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal administration of vasopressin antiserum induces long-term deficits on active and passive avoidance behaviour in rats.
    Moratalla R; Borrell J; Sanchez-Franco F; Del Rio J
    Behav Brain Res; 1987 Mar; 23(3):231-7. PubMed ID: 3580108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.
    Sahgal A
    Psychopharmacology (Berl); 1986; 90(4):494-8. PubMed ID: 3101105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohypophyseal peptide levels in CSF and plasma during passive avoidance behavior in rats.
    Mens WB; van Egmond MA; de Rotte AA; van Wimersma Greidanus TB
    Horm Behav; 1982 Dec; 16(4):371-82. PubMed ID: 7160838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.